The original Lancefield precipitation method for the serogrouping of beta-hemolytic streptococci has been largely superseded by more rapid and sensitive methods, such as latex agglutination. Latex agglutination has also been used for the rapid detection of bacteria or antigens in blood cultures (12) (13) (14) , body fluids (1, 5) , and swabs taken from various sites of infection (2, 3, 7, 10) . Although previous studies indicate that reasonably reliable results can be obtained, the potential for antigenic cross-reactions among different bacteria has not been fully appreciated.
Recently, Wetkowski et. al. (14) , using staphylococcal coagglutination, reported that all five of their Streptococcus pneumoniae isolates cross-reacted with a streptococcal group C reagent. Shlaes et. al. (12) , using a latex agglutination method, similarly found that 9 of 11 strains of S. pneumoniae cross-reacted with a group C reagent. Other reports have documented Streptococcus faecalis and Listeria monocytogenes cross-reacting with a latex group G reagent (4) and Klebsiella pneumoniae cross-reacting with a group C latex reagent (10) . This study was designed to examine the extent of cross-reactivity between S. pneumoniae and streptococcal latex grouping reagents and thus to determine the importance of cross-reactions in the clinical laboratory.
We first examined the problem of cross-reactivity by testing 23 blood cultures containing S. pneumoniae by using BACTEC 6B and 7D bottles (Johnston Laboratories, Towson, Md.) and Streptex latex agglutination reagents (groups A, B, C, D, F, and G; Wellcome Reagents Ltd., Beckenham, England). Twelve were positive cultures from clinical specimens, and ten were simulated. The latter were prepared by inoculating 6B and 7D bottles with S. pneumoniae strains isolated from clinical blood cultures. The inoculum was prepared by suspending colonies from a blood agar plate in physiological saline and adjusting the concentration to about i03 organisms per ml. A Helber chamber was used to enumerate the bacteria. A 1-ml sample was inoculated into each culture bottle; the bottles were then incubated for 18 to 24 h at 35°C. After incubation, 1-ml samples of the blood cultures were centrifuged at 1,500 x g for 5 min and the supernatant fluids were tested directly without extraction.
We then examined 75 clinical isolates of S. pneumoniae for the presence of cross-reacting antigens. The isolates were from various sources and were identified by bile * Corresponding author.
solubility and susceptibility to optochin. In addition, all were serotyped by using Danish antisera (Statens Seruminstitut, Copenhagen, Denmark) and the Quellung reaction. These strains were stored in skim milk at -70°C and subcultured onto plates containing Columbia agar base (Oxoid Ltd., Basingstoke, Hampshire, England) supplemented with 5% horse blood. Colonies were subjected to enzymatic extraction and tested with the Streptex latex reagents according to the instructions from the manufacturer.
Of the 12 clinical blood cultures positive for S. pneumoniae, 11 gave a strong reaction with the group C reagent alone and 1 gave a weak reaction with the group F reagent. Nine of the ten simulated blood cultures reacted with the group C latex. Eight reacted strongly, one reacted weakly, and one did not react with any of the six grouping reagents.
Of the 75 strains from the blood agar plates tested, 73
cross-reacted with the group C reagent (Table 1) . Sixty-eight had strong reactions, and five had only weak reactions. Three of the strains with antigens cross-reactive with the group C reagent also reacted weakly with the group F reagent. To exclude the possibility that the cross-reactions were due to the nature of the group-specific antibodies coupled to the latex and therefore a characteristic of the Streptex reagents, the aforementioned tests were repeated using the Oxoid streptococcal latex grouping kit. Identical results were obtained, except for the lack of any cross-reaction with the group F reagent. These comparable results also indicated that any difference in the enzyme preparations used for antigen extraction did not have a significant effect. The Oxoid system incorporates the use of a new rapid enzymatic extraction procedure designed to improve the yield of antigens from group D streptococci (Oxoid instructional literature), and thus the enzyme preparation is different from that of the Streptex system. These findings suggest that most clinical isolates of S. pneumoniae possess antigen(s) cross-reactive with the group C polysaccharide of beta-hemolytic streptococci. The distribution of this cross-reactivity does not appear to be related to any particular serotype of S. pneumoniae ( Table 1) , implying that the cross-reacting antigen(s) is in the cell wall rather than in the polysaccharide capsule. Further studies are required for elucidation. Further evidence for this location of the cross-reacting antigen is that the C polysaccharide of S. pneumoniae contains N-acetylgalactosamine as a major constituent (6, 11) and the specificity of the streptococcal group C carbohydrate is also determined by an N- acetylgalactosamine residue (9) . Although it thus appears that our findings could have been theoretically predicted, in practice this may not occur. Krause and McCarty (9) failed to find any cross-reactivity between the streptococcal group C carbohydrate and the blood-group A substance, the specificity of both being associated with N-acetylgalactosamine end groups. Although we found that most of the S. pneutmoniae strains possessed antigens cross-reactive with the group C carbohydrate, two failed to show this reaction. These were not of the same serotype, and the reasons for the lack of a reaction are not clear. Further studies would help in the understanding of these reactions. Moreover, the distribution of strains that demonstrate such a cross-reaction does not appear to be related to the clinical forms of infection, and thus the biological significance of the cross-reacting antigen(s) is uncertain. It would be interesting to see whether antibodies raised against the group C streptococcal antigen are protective against infection with S. pneumoniae. The results of this study further highlight the problem of mistaking S. pneumoniae for group C streptococci when blood cultures growing streptococci are tested directly by latex agglutination. This may not be a significant problem, provided that these blood cultures are also tested with a latex reagent directed against S. pneumoniae and undergo a rapid bile solubility test (8, 10 
